MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, INBX made $1,300K in revenue. -$140,055K in net income. Net profit margin of -10773.46%.

Income Overview

Revenue
$1,300K
Net Income
-$140,055K
Net Profit Margin
-10773.46%
EPS
-$9.04
Unit: Thousand (K) dollars
Revenue Breakdown
    • Revenues

Income Statement
2025-12-31
Total revenue
1,300
Research and development
113,028
General and administrative
23,297
Total operating expenses
136,325
Loss from operations
-135,025
Gain related to transaction with acquirer
0
Interest expense
12,196
Interest income
7,549
Other income (expense), net
-381
Total other income (expense)
-5,028
Income (loss) before provision for income taxes
-140,053
Provision for income taxes
2
Net income (loss)
-140,055
Basic EPS
-9.04
Diluted EPS
-9.04
Basic Average Shares
15,487,000
Diluted Average Shares
15,487,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net income (loss)-$140,055K Income (loss) beforeprovision for income taxes-$140,053K Provision for income taxes$2K Revenues$1,300K Loss from operations-$135,025K Total other income(expense)-$5,028K Total revenue$1,300K Interest income$7,549K Total operatingexpenses$136,325K Interest expense$12,196K Other income(expense), net-$381K Research and development$113,028K General andadministrative$23,297K

Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences, Inc. (INBX)